Evgeniya V Kaigorodova
Overview
Explore the profile of Evgeniya V Kaigorodova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaigorodova E, Kozik A, Grishchenko M
Curr Cancer Drug Targets
. 2024 Jul;
PMID: 39021190
Metastasis is one of the key concepts in modern oncology, which connects the movement of cancer cells in the body with changes in their characteristics and functions. The review examines...
2.
Kaigorodova E, Kozik A, Zavaruev I, Grishchenko M
Biochemistry (Mosc)
. 2022 May;
87(4):380-390.
PMID: 35527376
Cancer is one of the most common diseases worldwide, and its treatment is associated with many challenges such as drug and radioresistance and formation of metastases. These difficulties are due...
3.
Savelieva O, Tashireva L, Kaigorodova E, Buzenkova A, Mukhamedzhanov R, Grigoryeva E, et al.
Int J Mol Sci
. 2020 Apr;
21(8).
PMID: 32316333
The presence of stem and epithelial-mesenchymal-transition (EMT) features in circulating tumor cells (CTCs) determines their invasiveness, adaptability to the microenvironment, and resistance to proapoptotic signals and chemotherapy. It also allows...
4.
Tashireva L, Zavyalova M, Savelieva O, Gerashchenko T, Kaigorodova E, Denisov E, et al.
Front Oncol
. 2020 Mar;
10:50.
PMID: 32154161
The identification of tumor cells that can be potential metastatic seeds would reach two key aims-prognosis of metastasis risk and appointment of the optimal adjuvant therapy to prevent metastatic disease....
5.
Perelmuter V, Tashireva L, Savelieva O, Denisov E, Kaigorodova E, Zavyalova M, et al.
Breast Cancer (Dove Med Press)
. 2019 Jul;
11:209-219.
PMID: 31308736
Chemotherapy, along with surgery and radiotherapy, is a key treatment option for malignant tumors. Neoadjuvant chemotherapy (NACT) reduces the tumor size and enables total tumor resection. In addition, NACT is...
6.
Kaigorodova E, Savelieva O, Tashireva L, Tarabanovskaya N, Simolina E, Denisov E, et al.
Molecules
. 2018 Mar;
23(4).
PMID: 29565320
The biological properties of circulating tumor cells (CTCs), and their dynamics during neoadjuvant chemotherapy are important, both for disease progression prediction and therapeutic target determination, with the aim of preventing...
7.
Karbyshev M, Grigoryeva E, Volkomorov V, Kremmer E, Huber A, Mitrofanova I, et al.
Pathol Oncol Res
. 2017 Jun;
24(2):427-438.
PMID: 28584893
Transmembrane prostate androgen-induced protein 1 (TMEPAI) is a single-span membrane protein, functionally involved in transforming growth factor beta signaling pathway. The particular protein presented in cells in three isoforms, which...
8.
Kaigorodova E, Zavyalova M, Bychkov V, Perelmuter V, Choynzonov E
Cancer Biomark
. 2016 Aug;
17(2):145-53.
PMID: 27540972
Background: The small heat shock protein 27 kDA (Hsp27) acts as an ATP-independent chaperone in protein folding, but is also implicated in architecture of the cytoskeleton, cell migration, metabolism, cell...
9.
Kaigorodova E, Zavyalova M, Bogatyuk M, Tarabanovskaya N, Slonimskaya E, Perelmuter V
Cancer Biomark
. 2014 Dec;
15(2):143-50.
PMID: 25519015
Background: Heat shock protein beta-1 (HspB1) is a chaperone of the sHsp (small heat shock protein). The common functions of sHsps are chaperone activity, inhibition of apoptosis, regulation of cell...
10.
Kaigorodova E, Bogatyuk M
Curr Cancer Drug Targets
. 2014 Sep;
14(8):713-26.
PMID: 25258164
This review systematically examines the literature and data on the prognostic significance of heat shock proteins (heat shock protein - Hsp) Hsp27, Hsp60, Hsp70, Hsp90 in various cancers. Our analysis...